← Back to Clinical Trials
Recruiting NCT06594107

NCT06594107 Factors for the Onset and Course of Axial Spondylitis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06594107
Status Recruiting
Phase
Sponsor Karolinska Institutet
Condition Axial Spondyloarthritis
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2022-09-01
Primary Completion 2035-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2022-09-01 with a primary completion date of 2035-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In a research project, investigators want to study the course of the disease of axial spondylitis: the causes of disease onset, prognosis, and treatment effects. The goal is to improve treatment and in the long run also prevention of the disease. The project has a focus on the body\'s own substance prostaglandin, and its proinflammatory role in spondylitis, but also other substances may be analyzed in blood and urine samples. The purpose of the research project is include newly diagnosed treatment-naive patients with axial spondyloarthritis, to follow them after 1 and 2 years after treatment start, to collect clinical data, questionnaires, blood and urinsamples to find blood or urine markers that can be used for precision therapy of axial spondylitis.

Eligibility Criteria

Inclusion Criteria: * newly diagnosed patients with axial spondyloarthritis * treatment-naive * 18 years of age or older * Swedish-speaking * Able to give informed consent Exclusion Criteria: * DMARD treatment, * ongoing infection * ongoing malignancy

Contact & Investigator

Central Contact

Per-Johan Jakobsson, MD PhD Professor

✉ per-johan-jakobsson@ki.se

📞 0725848033

Frequently Asked Questions

Who can join the NCT06594107 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Axial Spondyloarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06594107 currently recruiting?

Yes, NCT06594107 is actively recruiting participants. Contact the research team at per-johan-jakobsson@ki.se for enrollment information.

Where is the NCT06594107 trial being conducted?

This trial is being conducted at Huddinge, Sweden, Stockholm, Sweden.

Who is sponsoring the NCT06594107 clinical trial?

NCT06594107 is sponsored by Karolinska Institutet. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology